SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-107034
Filing Date
2020-09-21
Accepted
2020-09-21 17:02:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2031018-3_424b5.htm 424B5 268171
2 GRAPHIC tm2031018d1_424b5img002.jpg GRAPHIC 3444
3 GRAPHIC lg_checkpoint-lr.jpg GRAPHIC 22219
4 GRAPHIC tm2031018d1_424b5img03.jpg GRAPHIC 4132
  Complete submission text file 0001104659-20-107034.txt   310679
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221493 | Film No.: 201187043
SIC: 2834 Pharmaceutical Preparations